Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss.
Liu, Huayang
Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss. [electronic resource] - Nature medicine 01 2019 - 95-102 p. digital
Publication Type: Journal Article
1546-170X
10.1038/s41591-018-0302-5 doi
Adenosine Deaminase--metabolism
Animals
Cell Line, Tumor
Gene Expression Profiling
Humans
Interferons--metabolism
Membrane Proteins--metabolism
Mice, Nude
RNA, Small Interfering--metabolism
RNA-Binding Proteins--metabolism
Signal Transduction
Suppression, Genetic
Xenograft Model Antitumor Assays
Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss. [electronic resource] - Nature medicine 01 2019 - 95-102 p. digital
Publication Type: Journal Article
1546-170X
10.1038/s41591-018-0302-5 doi
Adenosine Deaminase--metabolism
Animals
Cell Line, Tumor
Gene Expression Profiling
Humans
Interferons--metabolism
Membrane Proteins--metabolism
Mice, Nude
RNA, Small Interfering--metabolism
RNA-Binding Proteins--metabolism
Signal Transduction
Suppression, Genetic
Xenograft Model Antitumor Assays